Evaluation of antiaggregatory activity of flavonoid aglycone series

Nutrition Journal

Volumn 10, Issue 1, 2011, Pages

  Bojić, Mirza ^a   Debeljak, Željko ^a,b   Tomčiić, Maja ^c   Medić Šari, Marica ^a   Tomić, Siniša ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b CHC Osijek   (Croatia)

^c CROATIAN INSTITUTE OF TRANSFUSION MEDICINE   (Croatia)

^d Agency for Medicinal Products and Medical Devices   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYFLAVONE; 3,6 DIHYDROXYFLAVONE; 3,7 DIHYDROXYFLAVONE; 6 HYDROXYFLAVONE; 7 HYDROXYFLAVONE; ACACETIN; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; APIGENIN; CHRYSIN; CHRYSIN DIMETHYLETHER; DIOSMETIN; FISETIN; FLAVONE; FLAVONOID AGLYCONE; GALANGIN; HESPERETIN; HOMOERIODICTYOL; ISORHAMNETIN; ISOSAKURANETIN; LUTEOLIN; PINOCEMBRIN 7 METHYLETHE; PINOCEMBRINE; PLANT MEDICINAL PRODUCT; QUERCETIN; RHAMNETIN; SYRINGETIN; TANGERETIN; TECTOCHRYSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; FLAVONOID; GLYCOSIDE;

ARTICLE; BLOOD SAMPLING; DIETARY INTAKE; DRUG SCREENING; DRUG STRUCTURE; IN VITRO STUDY; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; DRUG EFFECT; HUMAN;

ADENOSINE DIPHOSPHATE; FLAVONOIDS; GLYCOSIDES; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 79960034938     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-10-73     Document Type: Article

References (29)

1. Sweetman S, Martindale: The Complete Drug Reference London: Pharmaceutical Press 2011
2. Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. de Lange DW, Verhoef S, Gorter G, Kraaijenhagen RJ, van de Wiel A, Akkerman JW, Alcohol Clin Exp Res 2007 31 1308 1314 10.1111/j.1530-0277.2007.00439.x 17559545 (Pubitemid 47063132)
3. Cardioprotective actions of grape polyphenols. Leifert WR, Abeywardena MY, Nutr Res 2008 28 729 737 10.1016/j.nutres.2008.08.007 19083481
4. Green tea, the "Asian paradox," and cardiovascular disease. Sumpio BE, Cordova AC, Berke-Schlessel DW, Qin F, Chen QH, J Am Coll Surg 2006 202 813 825 10.1016/j.jamcollsurg.2006.01.018 16648021
5. From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. Medi-ari M, Rastija V, Boji M, Male Nutr J 2009 8 33 10.1186/1475-2891-8-33 19624827
6. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. Akhlaghi M, Bandy B, J Mol Cell Cardiol 2009 46 309 317 10.1016/j.yjmcc.2008.12.003 19133271
7. Complex effects of different green tea catechins on human platelets. Lill G, Voit S, Schrör K, Weber AA, FEBS Lett 2003 546 265 270 10.1016/S0014-5793(03)00599-4 12832052 (Pubitemid 36782423)
8. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. Pignatelli P, Di Santo S, Buchetti B, Sanguigni V, Brunelli A, Violi F, FASEB J 2006 20 1082 1089 10.1096/fj.05-5269com 16770007 (Pubitemid 44943904)
9. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Dell'Agli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E, Br J Nutr 2008 99 945 951 17927845
10. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Freedman JE, Parker C, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD, Circulation 2001 103 2792 2798 11401934 (Pubitemid 32550066)
11. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. Guerrero JA, Lozano ML, Castillo J, Benavente-García O, Vicente V, Rivera J, J Thromb Haemost 2005 3 369 376 10.1111/j.1538-7836.2004. 01099.x 15670046 (Pubitemid 41623628)
12. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Nakahata N, Pharmacol Ther 2008 118 18 35 10.1016/j. pharmthera.2008.01.001 18374420
13. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, Katan MB, Am J Clin Nutr 1998 67 255 262 9459373 (Pubitemid 28076717)
14. Antiplatelet prenylflavonoids from Artocarpus communis. Weng JR, Chan SC, Lu YH, Lin HC, Ko HH, Lin CN, Phytochemistry 2006 67 824 829 10.1016/j.phytochem.2006.01.030 16516939
15. Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. Heptinstall S, May J, Fox S, Kwik-Uribe C, Zhao L, J Cardiovasc Pharmacol 2006 47 Suppl 2 197 205 16794458
16. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM, J Thromb Haemost 2004 2 2138 2145 10.1111/j.1538-7836.2004.01067.x 15613018 (Pubitemid 40185773)
17. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Jin YR, Han XH, Zhang YH, Lee JJ, Lim Y, Chung JH, Yun YP, Atherosclerosis 2007 194 144 152 10.1016/j.atherosclerosis.2006.10.011 17092506 (Pubitemid 47464316)
18. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F, Am J Clin Nutr 2000 72 1150 1155 11063442
19. Anti-platelet and membrane-rigidifying flavonoids in brownish scale of onion. Furusawa M, Tsuchiya H, Nagayama M, Tanaka T, Nakaya K, Iinuma M, J Health Sci 2003 49 475 480 10.1248/jhs.49.475 (Pubitemid 41289070)
20. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Hendrich AB, Acta Pharmacol Sin 2006 27 27 40 10.1111/j.1745-7254.2006.00238.x 16364208 (Pubitemid 43051943)
21. Primary Hemostasis. O'Malley BA, Clinical Laboratory Hematology New York: Pearson, McKenzie SB, Williams JL, 2 2010 612 638
22. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Boina N, Bradamante V, Lovri M, Arh Hig Rada Toksikol 2009 60 217 242 19581216
23. Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships. Navarro-Nú̃ez L, Castillo J, Lozano ML, Martínez C, Benavente-García O, Vicente V, Rivera J, J Agric Food Chem 2009 57 1589 1594 10.1021/jf803041k 19182941
24. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Hertog MG, Hollman PC, Katan MB, Kromhout D, Nutr Cancer 1993 20 21 29 10.1080/01635589309514267 8415127 (Pubitemid 23225364)
25. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB, Am J Clin Nutr 1995 62 1276 1282 7491892
26. Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy. Stalmach A, Mullen W, Steiling H, Williamson G, Lean ME, Crozier A, Mol Nutr Food Res 2010 54 323 334 10.1002/mnfr.200900194 19937856
27. Flavanone plasma pharmacokinetics from blood orange juice in human subjects. Gardana C, Guarnieri S, Riso P, Simonetti P, Porrini M, Br J Nutr 2007 98 165 172 10.1017/S0007114507699358 17367568 (Pubitemid 47272161)
28. Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects. Bredsdorff L, Nielsen IL, Rasmussen SE, Cornett C, Barron D, Bouisset F, Offord E, Williamson G, Br J Nutr 2010 103 1602 1609 10.1017/S0007114509993679 20100371
29. Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. Mullen W, Archeveque MA, Edwards CA, Matsumoto H, Crozier A, J Agric Food Chem 2008 56 11157 11164 10.1021/jf801974v 19007165